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INTRODUCTION
Cigarette smoking is one of the major cause and established risk factor of premature death due to respiratory and cardiovascular illness in developing and developed countries 1, 2 . Approximately there were 800 million smokers in developed countries as compare to 300 million in developing countries and it was the third leading cause of casualty in the United States 3 . An estimated 443,000 people die of smokingrelated diseases in the United States 4 . Nearly four-fi fths of estimated 1.1 million smokers live in low or middleincome countries 5 . The number of female smokers is higher in Nepal in comparison to other countries especially from hilly and Himalayan regions in young community 6 . Cigarette smoke is composed of over 4000 chemicals many of which are strong oxidizing agents and chemical carcinogens 7 . Tobacco kills more people than AIDS, alcohol, car crashes, murder, suicides and fi res. Cigarette smoking not only causes injury to active but passive smokers also. Risk of coronary heart disease is increased by two-to four folds in smoking MJ SBH J a nu ary -J un e 2 013 | Vo l 1 2| Is s u e 1 and tobacco chewing 8 . Smoking and tobacco chewing leads to change in the concentration of serum total cholesterol, triglycerides, LDL, VLDL and HDL. The changes in lipid profi le leads to atherosclerosis which compounded the risk of getting cardiovascular disease. In our present study, the main objective was to assess the blood lipid profi le among smokers and tobacco chewers to ascertain cardiovascular risk.
METHODS
It was a hospital based case control study carried out using data retrieved from the register maintained in the Department of Biochemistry of Institute of Medicine Teaching Hospital, Nepal between 1st January, 2008 and 31st December, 2009. Among 150 subjects enrolled in this study, 50 were current smokers, 50 were tobacco chewers and 50 were normal healthy controls. Questionnaires were used to assess the smokers and tobacco chewers and control for this study. Current smokers and chewers were only included and those who were old smokers and chewers were excluded from this study. The patients receiving lipid lowering agents, those having renal, hepatic, thyroid disorders and patients who were taking non cardiac drugs which affect the lipid profi le were excluded from the study.
The variables collected were age, gender, total cholesterol, triglycerides, HDL, LDL, and VLDL. Estimation of total cholesterol and triglycerides was done by CHOD-PAP 9 and GPO-PAP method respectively. Estimation of high density lipoproteins was done by kinetic enzymatic method 10 . The values of LDL and VLDL were obtained by the Friedewald formula 11 . All these laboratory parameters were analyzed using Human reagent kits and semi auto analyzer (Humalyser 3500, Germany).
Preceding the study, approval for the study was obtained from the institutional research ethical committee. Analysis was done using descriptive statistics and testing of hypothesis. The data was analyzed using 
RESULTS
The mean values of serum total cholesterol (257.5±22.6 mg/dl), LDL (186.6±24.0 mg/dl), TG (139.4±39.8 mg/ dl) were signifi cantly higher in smokers when compared to controls. In contrast to that HDL (42.9±1.5 mg/dl) was lower when compared to controls (44.8±1.9) mg/ dl) ( Table 1 ).
The mean values for TG (141.5±34.9 mg/dl), total cholesterol (260.3 ±21.2 mg/dl), LDL (188.5±26.0 mg/dl) in tobacco chewers was signifi cantly higher when compared to controls. There was also signifi cant difference in HDL level for tobacco chewers in comparison to controls. 
DISCUSSION
It has been accounted that prevalence of cardiovascular disease is unswervingly linked to number of cigarettes smoked and tobacco chewed. Risk of unexpected casualty raises by 3-6 times in smokers than in non smokers. The present study illustrated that the signifi cant higher levels of total cholesterol 257.5±22.6 mg/dl in smokers as compared to that of controls 173.2±32.6 mg/dl. Our results concurred with the fi ndings of Friedman et al 12 .
In contrast to that HDL levels showed statistically signifi cant decrease in smokers 42.9±1.5 MJ SBH J a nu ary -J un e 2 0 13 | Vo l 1 2| Is s u e 1 mg/dl as compared to controls 44.8±1.9 mg/dl. These results are in conformity with those of Criqui and his collegues 13 . The cigarette smoking has been related with altered total cholesterol, triglycerides levels, reduced fi brinolysis, augmented fi brinogen levels and variation in endothelial and platelet functions, which can lead to atherosclerosis. Similarly in tobacco chewers, levels of total cholesterol 260.3±21.2 mg/dl and triglycerides 141.5±34.9 mg/dl were signifi cantly higher when compared to the levels of total cholesterol 173.2±32.6 mg/dl and triglycerides115.0±25.12 mg/ dl in controls respectively. Nicotine which is main constituents of tobacco has a substantial infl uence on elevating the lipid levels in blood 14 . Nicotine stimulates sympathetic adrenal system leading to increased secretion of catecholamines resulting in increased lipolysis and increased concentration of plasma free fatty acids (FFA), which further results in increased secretion of hepatic FFAs and hepatic triglycerides along with VLDL in the blood stream 15 .
